Advertisement
Screener

DataMeds AI, Inc. (MEDS) Cash and Cash Equivalents

2.8 / 5 stars · 68/120 Roast Me

DataMeds AI, Inc. Cash and Cash Equivalents

DataMeds AI, Inc. (MEDS) had Cash and Cash Equivalents of $2.46 million as of 2026-06-30, per its 10-Q filed 2026-08-17.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-17

  • 2026-06-30: Cash and Cash Equivalents, at Carrying Value $2.46M.
  • 2026-03-31: Cash and Cash Equivalents, at Carrying Value $51.73K.
  • 2025-12-31: Cash and Cash Equivalents, at Carrying Value $42.57K.
  • 2025-09-30: Cash and Cash Equivalents, at Carrying Value $4.23M.
Period endCash and Cash Equivalents, at Carrying Value
2026-06-30$2.46M
10-Q · filed 2026-08-17
2026-03-31$51.73K
10-Q · filed 2026-05-19
2025-12-31$42.57K
10-Q · filed 2026-08-17
2025-09-30$4.23M
10-Q · filed 2025-11-19
2025-06-30$419.94K
10-Q · filed 2025-08-19
2025-03-31$2.52M
10-Q · filed 2025-05-12
2024-12-31$1.03M
10-K · filed 2026-03-20
2023-12-31$1.36K
10-K · filed 2025-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
HWH International Inc. (HWH)United States$0.021B-4.08
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
HERBALIFE LTD. (HLF)$1.281B8.39
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
Cencora, Inc. (COR)United States$59.130B20.57
MCKESSON CORP (MCK)United States$101.317B19.78